Despite proven benefits of LDL-C lowering among those with ASCVD, adherence to statins remains low. However, very little real-world data exists on the effect of long-term statin adherence on cardiovascular… Click to show full abstract
Despite proven benefits of LDL-C lowering among those with ASCVD, adherence to statins remains low. However, very little real-world data exists on the effect of long-term statin adherence on cardiovascular outcomes. Patients >18 years first diagnosed with ASCVD (CAD/MI, CVD, and PAD) between 1999
               
Click one of the above tabs to view related content.